BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7782 related articles for article (PubMed ID: 22780971)

  • 1. [Generation of a herpes simplex virus-permissive mouse melanoma cell line B16RHSV].
    Zhuang XF; Zhou AP; Shi GL; Han XP; Li J; Zhang Y; Zhang YH; Zhang SR; Liu BL
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):187-91. PubMed ID: 22780971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
    Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
    Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced resistance to herpes simplex virus type 1 infection in transgenic mice expressing a soluble form of herpesvirus entry mediator.
    Ono E; Yoshino S; Amagai K; Taharaguchi S; Kimura C; Morimoto J; Inobe M; Uenishi T; Uede T
    Virology; 2004 Mar; 320(2):267-75. PubMed ID: 15016549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D.
    Sciortino MT; Medici MA; Marino-Merlo F; Zaccaria D; Giuffrè-Cuculletto M; Venuti A; Grelli S; Mastino A
    Cell Microbiol; 2008 Nov; 10(11):2297-311. PubMed ID: 18671825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
    Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
    Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.
    Warner MS; Geraghty RJ; Martinez WM; Montgomery RI; Whitbeck JC; Xu R; Eisenberg RJ; Cohen GH; Spear PG
    Virology; 1998 Jun; 246(1):179-89. PubMed ID: 9657005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
    Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
    J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and expression of human stathmin gene eukaryotic expression vector and its effect on esophageal cancer cells].
    Wang F; Wang LX; Wang RL; Fan QX; Zhao PR
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):179-83. PubMed ID: 18756931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of herpes virus entry mediator as a factor linked to obesity.
    Bassols J; Moreno JM; Ortega F; Ricart W; Fernandez-Real JM
    Obesity (Silver Spring); 2010 Feb; 18(2):239-46. PubMed ID: 19680232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
    Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of the HveA homolog specified by African green monkey kidney cells with a herpes simplex virus expressing the green fluorescence protein.
    Foster TP; Chouljenko VN; Kousoulas KG
    Virology; 1999 Jun; 258(2):365-74. PubMed ID: 10366573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells.
    Cai G; Wang H; Qin Q; Zhang J; Zhu Z; Liu M; Shen Q
    Cardiovasc Res; 2009 Dec; 84(3):425-33. PubMed ID: 19570810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus entry mediator associates in infected cells in a complex with viral proteins gD and at least gH.
    Perez-Romero P; Perez A; Capul A; Montgomery R; Fuller AO
    J Virol; 2005 Apr; 79(7):4540-4. PubMed ID: 15767456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency.
    Wahl C; Wegenka UM; Leithäuser F; Schirmbeck R; Reimann J
    J Immunol; 2009 Apr; 182(8):4521-8. PubMed ID: 19342625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human endostatin gene transfected adult skin melanoma cells].
    Xiao GH; Luo CQ; Tang GM; Zhou JD
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):677-81. PubMed ID: 16708808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies on inhibition of malignant melanoma growth by gene transfer of adenovirus-mediated averse vascular endothelial growth factor165].
    Cui Z; Cen Y; Zhang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 May; 20(5):499-503. PubMed ID: 16752833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 390.